利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

106 条记录 (耗时 0.029 秒)

    SLIDE ASSIST MECHANISM AMD DRAW-IN UNIT
    22.
    发明申请
    SLIDE ASSIST MECHANISM AMD DRAW-IN UNIT 有权
    幻灯片辅助机构AMD绘图单元

    公开(公告)号：US20120124778A1

    公开(公告)日：2012-05-24

    申请号：US13380794

    申请日：2010-06-24

    申请人： Masakazu Sato

    发明人： Masakazu Sato

    IPC分类号： E05D15/06

    CPC分类号： E05F5/027 ,  E05F1/16 ,  E05F5/003 ,  E05Y2201/412 ,  E05Y2201/424 ,  E05Y2800/00 ,  E05Y2800/73 ,  Y10T16/373

    摘要： A slide assist mechanism includes a case attached to one of a main body or a moving body; a slider disposed freely slidably in the case; a latch supported by the slider so as to be switched between a standby position which locks in a corresponding portion of the case and a draw-in position which releases the locking; a draw-in unit including an urging device; and an operation member attached to the another of the main body or the moving body and switching the latch from the standby position to the draw-in position, or switching the latch from the draw-in position to the standby position. When the latch is switched from the standby position to the draw-in position, due to an urging force which has been accumulated in the urging device, the slide assist mechanism allows the moving body to move from a first position to a second position on a main body side through the operation member. In the slider, the urging device is disposed on a lower surface side, and also one end in a sliding direction includes an attachment device for the urging device.

    摘要翻译： 滑动辅助机构包括附接到主体或移动体中的一个的壳体; 可自由滑动地设置在该壳体中的滑块; 由所述滑块支撑的闩锁，以便在锁定在所述壳体的相应部分中的待机位置与释放所述锁定的拉入位置之间切换; 包括推动装置的牵引单元; 以及操作构件，其附接到主体或移动体中的另一个，并且将闩锁从待机位置切换到拉入位置，或者将闩锁从拉入位置切换到待机位置。 当闩锁从待机位置切换到拉入位置时，由于已经积聚在推动装置中的推动力，滑动辅助机构允许移动体从第一位置移动到第二位置 主体侧通过操作构件。 在滑块中，推动装置设置在下表面侧，并且滑动方向上的一端包括用于推动装置的附接装置。

    METHOD AND DEVICE FOR GENERATING PSEUDORANDOM NUMBER, AND METHOD AND DEVICE FOR ENCRYPTION USING PSEUDORANDOM NUMBER
    23.
    发明申请
    METHOD AND DEVICE FOR GENERATING PSEUDORANDOM NUMBER, AND METHOD AND DEVICE FOR ENCRYPTION USING PSEUDORANDOM NUMBER 有权
    用于生成PSEUDORANDOR编号的方法和装置，以及使用PSEUDORANDOR编号加密的方法和装置

    公开(公告)号：US20100284533A1

    公开(公告)日：2010-11-11

    申请号：US12670299

    申请日：2008-07-16

    申请人： Osamu Kameda ,  Masakazu Sato

    发明人： Osamu Kameda ,  Masakazu Sato

    IPC分类号： G06F7/58 ,  H04L9/28

    CPC分类号： H04L9/0662 ,  H04N21/2347 ,  H04N21/4405

    摘要： Provided are a method and apparatus for generating a pseudo-random number which is unpredictable and which has a small memory work area, and also a method and apparatus for encrypting data, for each predetermined amount, based on the generated pseudo-random number. A seed is divided into a predetermined number of blocks, new blocks are created by calculating an exclusive-OR of the blocks being different from each other, and the new blocks are merged to generate a new pseudo-random number. The data is encrypted for each determined amount based on the generated pseudo-random number. At this time, a pseudo-random number to be used for the succeeding encryption is generated by using as a seed a predetermined amount of random number of the pseudo-random number used for the preceding encryption of the predetermined amount of data.

    摘要翻译： 提供了一种用于生成不可预测的并且具有小的存储器工作区域的伪随机数的方法和装置，以及用于基于所生成的伪随机数对每个预定量加密数据的方法和装置。 种子被分成预定数量的块，通过计算彼此不同的块的异或来创建新的块，并且新的块被合并以生成新的伪随机数。 基于生成的伪随机数，为每个确定的量对数据进行加密。 此时，通过使用预定量的用于预定数据量的先前加密的伪随机数的随机数作为种子来生成用于后续加密的伪随机数。

    Method for producing l-glutamic acid
    24.
    再颁专利
    Method for producing l-glutamic acid 有权
    生产L-谷氨酸的方法

    公开(公告)号：USRE41800E1

    公开(公告)日：2010-10-05

    申请号：US12485550

    申请日：2009-06-16

    申请人： Hiroshi Ueda ,  Takayuki Koda ,  Masakazu Sato

    发明人： Hiroshi Ueda ,  Takayuki Koda ,  Masakazu Sato

    IPC分类号： G12P13/14

    CPC分类号： C12N1/20 ,  C12P13/14

    摘要： A method for producing L-glutamic acid by fermentation, which comprises culturing a microorganism having L-glutamic acid-producing ability in a liquid medium of which pH is adjusted to a condition under which L-glutamic acid produced by the microorganism is allowed to be precipitated, to allow L-glutamic acid to be produced and accumulated with precipitation of L-glutamic acid accompanied, wherein an operation causing existence of L-glutamic acid crystals in the medium is performed when a concentration of L-glutamic acid in the medium is lower than the concentration at which spontaneous crystallization occurs.

    摘要翻译： 一种通过发酵生产L-谷氨酸的方法，其包括在将pH调节至由微生物产生的L-谷氨酸的条件下调节为具有L-谷氨酸生产能力的微生物，使其变为 伴随着L-谷氨酸的沉淀而生成和积累L-谷氨酸，其中当介质中的L-谷氨酸浓度为介质中时，进行介质中存在L-谷氨酸晶体的操作 低于发生自发结晶的浓度。

    Thiazole derivative
    25.
    发明授权
    Thiazole derivative 失效
    噻唑衍生物

    公开(公告)号：US07678810B2

    公开(公告)日：2010-03-16

    申请号：US10591614

    申请日：2005-03-04

    申请人： Masakazu Sato ,  Yuko Matsunaga ,  Hajime Asanuma ,  Hideaki Amada ,  Takeshi Koami ,  Tetsuo Takayama ,  Tetsuya Yabuuchi ,  Fumiyasu Shiozawa ,  Hironori Katakai ,  Hiroki Umemiya ,  Akiko Ikeda

    发明人： Masakazu Sato ,  Yuko Matsunaga ,  Hajime Asanuma ,  Hideaki Amada ,  Takeshi Koami ,  Tetsuo Takayama ,  Tetsuya Yabuuchi ,  Fumiyasu Shiozawa ,  Hironori Katakai ,  Hiroki Umemiya ,  Akiko Ikeda

    IPC分类号： A61K31/4439 ,  C07D277/62 ,  C07D317/48

    CPC分类号： A61K8/49 ,  A61Q7/00 ,  C07D417/04 ,  C07D417/06 ,  C07D417/14

    摘要： A thiazolylimidazole derivative represented by the formula or a pharmaceutically acceptable salt thereof, and an ALK5 inhibitor, an therapeutic agent for alopecia or a hair growth agent having the above as an active ingredient, wherein: X1 and X2 are different from each other and represent a sulfur atom or a carbon atom; R1 represents a phenyl group; a substituted phenyl group; a phenyl group condensed with a hetero aromatic ring; a pyridyl group; or a pyridyl group condensed with a hetero aromatic ring; R2 represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkyl group having 1 to 6 carbon atoms substituted with 1 to 5 halogen atoms, an alkoxy group having 1 to 6 carbon atoms, an alkanoyl group having 1 to 5 carbon atoms, or a hydroxyalkyl group having 1 to 6 carbon atoms, A represents a group which is represented by the formula. The present invention provides an inhibitory substance against ALK5 which is a TGF-β type I receptor and provides a hair growth stimulant or a hair growth agent based on its novel activities.

    摘要翻译： 由下式表示的噻唑咪唑衍生物或其药学上可接受的盐，以及ALK5抑制剂，秃发治疗剂或具有上述作为活性成分的毛发生长剂，其中：X1和X2彼此不同，表示 硫原子或碳原子; R1表示苯基; 取代的苯基; 与杂芳环稠合的苯基; 吡啶基; 或与杂芳环稠合的吡啶基; R2表示氢原子，卤素原子，碳原子数1〜6的烷基，碳原子数1〜5的碳原子数1〜5的烷基，碳原子数1〜6的烷氧基，烷氧基 具有1至5个碳原子，或具有1至6个碳原子的羟烷基，A表示由下式表示的基团。 本发明提供一种抗ALK5抑制物质，其为TGF- I型受体，并且基于其新的活性提供毛发生长兴奋剂或毛发生长剂。

    TRIAZOLE DERIVATIVE
    26.
    发明申请
    TRIAZOLE DERIVATIVE 失效
    三唑衍生物

    公开(公告)号：US20100041655A1

    公开(公告)日：2010-02-18

    申请号：US12278054

    申请日：2007-02-05

    申请人： Naoya Ono ,  Tetsuo Takayama ,  Fumiyasu Shiozawa ,  Hironori Katakai ,  Tetsuya Yabuuchi ,  Tomomi Ota ,  Makoto Yagi ,  Masakazu Sato

    发明人： Naoya Ono ,  Tetsuo Takayama ,  Fumiyasu Shiozawa ,  Hironori Katakai ,  Tetsuya Yabuuchi ,  Tomomi Ota ,  Makoto Yagi ,  Masakazu Sato

    IPC分类号： A61K31/5377 ,  C07D249/08 ,  A61K31/4196 ,  C07D403/12 ,  A61K31/497 ,  C07D413/14

    CPC分类号： C07D249/08

    摘要： An object of the present invention is to provide a compound having an action of inhibiting binding between S1P and its receptor, Edg-1 (S1P1), and is useful as a pharmaceutical compound. A compound or a pharmaceutically acceptable salt thereof, which compound is represented by the formula below (where A represents an oxygen atom, a sulfur atom, a group represented by Formula —SO—, a group represented by Formula —SO2— or the like, R1 represents a hydrogen atom, an alkyl group having 1-6 carbon atoms, or the like, R1A represents a hydrogen atom or the like, R2 represents an alkyl group having 1-6 carbon atoms, a cycloalkyl group having 3-6 carbon atoms, or the like, represents an aryl group, R4 represents a hydrogen atom or an alkyl group having 1-6 carbon atoms and optionally substituted with a carboxyl group, and R5 represents an alkyl group having 1-carbon atoms, a cycloalkyl group having 3-8 carbon atoms, an aryl group which is optionally substituted, or the like).

    摘要翻译： 本发明的目的是提供具有抑制S1P与其受体Edg-1（S1P1）结合的作用的化合物，可用作药物化合物。 一种化合物或其药学上可接受的盐，该化合物由下式表示（其中A表示氧原子，硫原子，由式-SO-表示的基团，由式-SO2-等表示的基团， R1表示氢原子，具有1-6个碳原子的烷基等，R1A表示氢原子等，R2表示具有1-6个碳原子的烷基，具有3-6个碳原子的环烷基 等表示芳基，R 4表示氢原子或具有1-6个碳原子并且任选被羧基取代的烷基，R 5表示具有1个碳原子的烷基，环烷基具有3个 -8个碳原子，任选取代的芳基等）。

    Method for selective preparation of aryl 5-thio-β-D-aldohexopyranosides
    27.
    发明授权
    Method for selective preparation of aryl 5-thio-β-D-aldohexopyranosides 失效
    芳基5-硫代-β-D-吡喃半乳糖苷的选择性制备方法

    公开(公告)号：US07250522B2

    公开(公告)日：2007-07-31

    申请号：US10521809

    申请日：2003-08-08

    申请人： Masakazu Sato ,  Hiroyuki Kakinuma ,  Hajime Asanuma

    发明人： Masakazu Sato ,  Hiroyuki Kakinuma ,  Hajime Asanuma

    IPC分类号： C07D335/02

    CPC分类号： C07H15/203 ,  C07H15/20

    摘要： The present invention provides a method for preparing an aryl 5-thio-β-D-aldohexopyranoside derivative of Formula (III), which comprises reacting a 5-thio-D-aldohexopyranose derivative of Formula (I) with Ar-OH of Formula (II) in the presence of a phosphine represented by PR11R12R13 and an azo reagent represented by R21—N═N—R22 in accordance with the following scheme

    摘要翻译： 本发明提供了制备式（III）的5-硫代-β-D-吡喃葡萄糖苷衍生物的方法，该方法包括使式（I）的5-硫代-D-去二羟基吡喃糖衍生物与式（I）的Ar-OH反应， II）在由PR 11和12 R 12表示的膦和由R 21表示的偶氮试剂存在下， SUP> -NNR <22>根据以下方案

    T-shaped connection frame
    29.
    发明授权
    T-shaped connection frame 失效
    T形连接架

    公开(公告)号：US5716155A

    公开(公告)日：1998-02-10

    申请号：US306478

    申请日：1994-09-15

    申请人： Suguru Yoshida ,  Kohki Sugawara ,  Masakazu Sato ,  Mituo Tuge ,  Harumichi Hino ,  Keiichi Sugiyama ,  Shigeru Kohmura

    发明人： Suguru Yoshida ,  Kohki Sugawara ,  Masakazu Sato ,  Mituo Tuge ,  Harumichi Hino ,  Keiichi Sugiyama ,  Shigeru Kohmura

    IPC分类号： B62D23/00 ,  B62D25/04 ,  B62D27/02 ,  B62D29/00 ,  B21D39/00

    CPC分类号： B62D25/04 ,  B62D23/005 ,  B62D27/023 ,  B62D27/026 ,  B62D29/008 ,  Y10T403/39 ,  Y10T403/3933 ,  Y10T403/4605 ,  Y10T403/4621 ,  Y10T403/4677 ,  Y10T403/60

    摘要： The present invention relates to a T-shaped connection frame for connecting car frames, in which a first member is connected to a second member via a joint member to form a "T." The joint member is formed by symmetrically dividing a rectangular tube between its two latch teeth located at the upper-center and lower-center inner walls. The rectangular tube also has protrusions at the left and right exterior walls. The joint member divided in this way has the latch teeth at the upper and lower tips of the mouth formed by the division and has the protrusion situated opposite the mouth so that the first member can be snapped on easily to this mouth and the second member can be attached to the protrusion at the opposite side. This structural arrangement makes the positioning of the frames very simple, obviates a make-shift attachment, and, at the same time, reduces the number of operation steps.

    摘要翻译： 本发明涉及一种用于连接轿厢框架的T形连接框架，其中第一构件经由接头构件连接到第二构件以形成“T.” 接头构件通过将矩形管对称地分配在位于中心中心和下中心内壁的两个闩锁齿之间来形成。 矩形管也在左右外壁上具有突起。 以这种方式分割的接头构件在由分隔开口形成的口的上端和下端处具有锁定齿，并且具有与口相对的突出部，使得第一构件可以容易地卡扣到该口上，并且第二构件可 附着在相对侧的突出部。 这种结构布置使得框架的定位非常简单，避免了换档附件，并且同时减少了操作步骤的数量。

    Thiazoline derivatives
    30.
    发明授权
    Thiazoline derivatives 失效
    噻唑啉衍生物

    公开(公告)号：US5478945A

    公开(公告)日：1995-12-26

    申请号：US371141

    申请日：1995-01-11

    申请人： Masakazu Sato ,  Akira Manaka ,  Keiko Takahashi ,  Yutaka Kawashima ,  Katsuo Hatayama

    发明人： Masakazu Sato ,  Akira Manaka ,  Keiko Takahashi ,  Yutaka Kawashima ,  Katsuo Hatayama

    IPC分类号： C07D277/56

    CPC分类号： C07D277/56

    摘要： A thiazoline derivative represented by the formula: ##STR1## [wherein R.sup.1 is cyano, carbamoyl, thiocarbamoyl, morpholinothiocarbonyl, alkylthioimidoyl, amidino, substituted amidino or imidazolin-2-yl, R.sup.2 is alkyl or aralkyl, R.sup.3 is hydrogen or alkyl, R.sup.4 is hydroxyl, alkoxy, substituted alkoxy or amino, l is an integer of 1 to 5] and salts thereof have fibrinogen receptor antagonism and cell adhesion factor antagonism, and are useful as therapeutic agents for ischemic diseases and atherosclerosis diseases, and metastasis inhibitory agents of tumors.

    摘要翻译： 由下式表示的噻唑啉衍生物：其中R1是氰基，氨基甲酰基，硫代氨基甲酰基，吗啉代硫代羰基，烷硫基亚氨基，脒基，取代的脒基或咪唑啉-2-基，R2是烷基或芳烷基，R3是氢或烷基 ，R4为羟基，烷氧基，取代的烷氧基或氨基，l为1〜5的整数]，其盐具有纤维蛋白原受体拮抗作用和细胞粘附因子拮抗作用，可作为缺血性疾病和动脉粥样硬化疾病及转移抑制因子的治疗剂 肿瘤药物。